A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...

The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. "Make ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the fiel ...

Among patients with type 2 diabetes, use of GLP-1 agonists may increase the risks for adhesive capsulitis and required ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may increase the risk of pulmonary aspiration among patients undergoing surgery ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

Boone Health is closing its bariatric clinic in Columbia because of lagging demand. "We're working to expand the high-demand ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

prescriptions for glucagon-like peptide 1 (GLP-1) receptor agonists soared by more than 132%. Some surgical centers are closing because the demand for bariatric surgery isn’t there anymore. Bariatric ...

And that's where surgery is probably the most effective," Schalet said. The rise in loose skin surgeries among GLP-1 users mirrors a trend previously seen with bariatric surgery patients.

Bariatric Surgery, GLP-1s, Or Both ... We still don’t have long-term safety data for GLP-1 agonists. We know that they’re incredibly effective and have completely transformed people’s ...

(HealthDay News) — The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist ... Otolaryngology-Head & Neck Surgery. Juan P.